Voyageur Minerals Ltd., VM: TSX-V Is developing near term cash flow on barite projects in BC, Canada and is actively exploring and developing lithium brine projects in Utah USA.
VM business plan is to immediately develop its advanced stage industrial grade barite deposit, Frances Creek, and create cash flow. Voyageur is developing barium contrast suspension products for the pharmaceutical industry.
VM is a Calgary based company which owns 100% interest in 3 barite deposits and owns a lithium deposit with a joint venture partner.
VM’s industrial grade barite is naturally occurring with grades as high as 99.26% BaSO4 in-situ, which is very rare.
Voyageur has strategically partnered with a Canadian pharmaceutical company who can formulate, manufacture and manage sales and distribution of the contrast products.
The structure of the JV is as follows: Voyageur provides USP grade barium sulfate from the Frances Creek property and Chief provides formulation, testing, quality control and GMP pharmaceutical manufacturing. The initial manufacturing and bottling will be carried out at the Calgary plant with capabilities to expand contrast development and manufacturing at the Mississauga plant. Each party receives 50% of the revenue less the cost of regulatory and marketing of the barium contrast within the JV. None of the assets (bottling plant or mine) reside within the JV.